Phytosterols and Cardiovascular Disease
Tóm tắt
Coronary heart disease is the leading cause of mortality worldwide. Elevated blood cholesterol levels are not only the major but also the best modifiable cardiovascular risk factor. Lifestyle modifications which include a healthy diet are the cornerstone of lipid-lowering therapy. So-called functional foods supplemented with plant sterols lower blood cholesterol levels by about 10–15%. In the recent revision of the ESC/EAS dyslipidemia guideline 2019, plant sterols are recommended for the first time as an adjunct to lifestyle modification to lower blood cholesterol levels. However, the German Cardiac Society (DGK) is more critical of food supplementation with plant sterols and calls for randomized controlled trials investigating hard cardiovascular outcomes. An increasing body of evidence suggests that plant sterols per se are atherogenic. This review discusses this controversy based on findings from in vitro and in vivo studies, clinical trials, and genetic evidence.
Tài liệu tham khảo
WHO. Cardiovascular diseases, fact sheet. 2017. https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds). Accessed 27 Mar 2011.
Stamler J. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded?: findings in 356222 primary screenees of the multiple risk factor intervention trial (MRFIT). JAMA. 1986;256:2823.
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90056 participants in 14 randomised trials of statins. Lancet 2005;366:1267–1278.
Jacobson TA, Maki KC, Orringer CE, et al. National lipid association recommendations for patient-centered management of dyslipidemia: part 2. J Clin Lipidol. 2015;9:S1-S122.e1.
NICE. Cardiovascular disease: risk assessment and reduction, including lipid modification. 2014. https://www.nice.org.uk/guidance/cg181.
Lichtenstein AH, Deckelbaum RJ. Stanol/sterol ester–containing foods and blood cholesterol levels: a statement for healthcare professionals from the nutrition committee of the council on nutrition, physical activity, and metabolism of the American Heart Association. Circulation. 2001;103:1177–9.
Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur Heart J. 2020;41:111–88. The revised ESC/EAS dyslipidemia guideline which included for the first time plant sterols as an option to lower blood cholesterol levels.
Cardiovascular disease: risk assessment and reduction, including lipid modification. National Institute for Health and Care Excellence (UK), London; 2016.
Bundesinstitut für Risikobewertung. Menschen mit normalen Cholesterinwerten sollten auf den Verzehr von Lebensmitteln mit zugesetzten Pflanzensterinen verzichten. 2008. https://mobil.bfr.bund.de/cm/343/menschen_mit_normalen_cholesterinwerten.pdf.
Kommission für Klinische Kardiovaskuläre Medizin der DGK, Weingärtner O, Landmesser U, März W, Katzmann JL, Laufs U. Kommentar zu den Leitlinien (2019) der ESC/EAS zur Diagnostik und Therapie der Dyslipidämien. Kardiologe. 2020;14:256–66. This review is the comment of the German Society of Cardiology (DGK) on the ESC/EAS dyslipidemia guidelines 2020 which calls for cardiovascular outcome studies prior to recommending plant sterols as a dietary supplement.
Valitova JN, Sulkarnayeva AG, Minibayeva FV. Plant sterols: diversity, biosynthesis, and physiological functions. Biochemistry (Mosc). 2016;81:819–34.
Davis HR, Zhu L, Hoos LM, et al. Niemann-Pick C1 like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis. J Biol Chem. 2004;279:33586–92.
Lee M-H, Lu K, Hazard S, et al. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet. 2001;27:79–83.
Berge KE. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science. 2000;290:1771–5.
Weingartner O, Bohm M, Laufs U. Controversial role of plant sterol esters in the management of hypercholesterolaemia. Eur Heart J. 2008;30:404–9.
Miettinen TA, Puska P, Gylling H, Vanhanen H, Vartiainen E. Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. N Engl J Med. 1995;333:1308–12.
Clifton PM, Noakes M, Sullivan D, Erichsen N, Ross D, Annison G, et al. Cholesterol-lowering effects of plant sterol esters differ in milk, yoghurt, bread and cereal. Eur J Clin Nutr. 2004;58:503–9.
Phytosterols market size, share & trends analysis report by product (beta-sitosterol, campesterol, stigmasterol), by application (pharmaceuticals, cosmetics, food ingredients), by region, and segment forecasts, 2020 - 2027. https://www.grandviewresearch.com/industry-analysis/phytosterols-market.
Ho SS, Pal S. Margarine phytosterols decrease the secretion of atherogenic lipoproteins from HepG2 liver and Caco2 intestinal cells. Atherosclerosis. 2005;182:29–36.
Fahy DM, O’Callaghan YC, O’Brien NM. Phytosterols: lack of cytotoxicity but interference with β-carotene uptake in Caco-2 cells in culture. Food Addit Contam. 2004;21:42–51.
Boberg KM, Pettersen KS, Prydz H. Toxicity of sitosterol to human umbilical vein endothelial cells in vitro. Scand J Clin Lab Invest. 1991;51:509–16.
Bao L, Li Y, Deng S-X, Landry D, Tabas I. Sitosterol-containing lipoproteins trigger free sterol-induced caspase-independent death in ACAT-competent macrophages. J Biol Chem. 2006;281:33635–49.
Feng B, Zhang D, Kuriakose G, Devlin CM, Kockx M, Tabas I. Niemann-Pick C heterozygosity confers resistance to lesional necrosis and macrophage apoptosis in murine atherosclerosis. Proc Natl Acad Sci. 2003;100:10423–8.
Moghadasian MH, McManus BM, Godin DV, Rodrigues B, Frohlich JJ. Proatherogenic and antiatherogenic effects of probucol and phytosterols in apolipoprotein E–deficient mice: possible mechanisms of action. Circulation. 1999;99:1733–9.
Moghadasian MH, McManus BM, Pritchard PH, Frohlich JJ. “Tall oil”–derived phytosterols reduce atherosclerosis in apoE-deficient mice. Arterioscler Thromb Vasc Biol. 1997;17:119–26.
Volger OL, Mensink RP, Plat J, Hornstra G, Havekes LM, Princen HMG. Dietary vegetable oil and wood derived plant stanol esters reduce atherosclerotic lesion size and severity in apoE3-Leiden transgenic mice. Atherosclerosis. 2001;157:375–81.
Wilund KR, Yu L, Xu F, Vega GL, Grundy SM, Cohen JC, et al. No association between plasma levels of plant sterols and atherosclerosis in mice and men. ATVB. 2004;24:2326–32.
Weingärtner O, Lütjohann D, Ji S, et al. Vascular effects of diet supplementation with plant sterols. J Am Coll Cardiol. 2008;51:1553–61.
Chen Q, Gruber H, Swist E, Coville K, Pakenham C, Ratnayake WM, et al. Dietary phytosterols and phytostanols decrease cholesterol levels but increase blood pressure in WKY inbred rats in the absence of salt-loading. Nutr Metab (Lond). 2010;7:11.
Plat J, Theuwissen E, Husche C, Lütjohann D, Gijbels MJJ, Jeurissen M, Shiri-Sverdlov R, van der Made I, Mensink RP. Oxidised plant sterols as well as oxycholesterol increase the proportion of severe atherosclerotic lesions in female LDL receptor+/− mice. Br J Nutr. 2014;111:64–70.
Grandgirard A, Martine L, Demaison L, Cordelet C, Joffre C, Berdeaux O, Semon E. Oxyphytosterols are present in plasma of healthy human subjects. Br J Nutr. 2004;91:101–6.
Yu L, Hammer RE, Li-Hawkins J, von Bergmann K, Lutjohann D, Cohen JC, Hobbs HH. Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc Natl Acad Sci. 2002;99:16237–42.
McDaniel AL, Alger HM, Sawyer JK, Kelley KL, Kock ND, Brown JM, Temel RE, Rudel LL. Phytosterol feeding causes toxicity in ABCG5/G8 knockout mice. Am J Pathol. 2013;182:1131–8.
Bhattacharyya AK, Connor WE. β-Sitosterolemia and xanthomatosis. J Clin Invest. 1974;53:1033–43.
Yoo E-G. Sitosterolemia: a review and update of pathophysiology, clinical spectrum, diagnosis, and management. Ann Pediatr Endocrinol Metab. 2016;21:7.
Buonuomo PS, Iughetti L, Pisciotta L, et al. Timely diagnosis of sitosterolemia by next generation sequencing in two children with severe hypercholesterolemia. Atherosclerosis. 2017;262:71–7.
Mymin D, Wang J, Frohlich J, Hegele RA. Aortic xanthomatosis with coronary ostial occlusion in a child homozygous for a nonsense mutation in ABCG8. Circulation. 2003;107:791–791.
Jones PJH, Shamloo M, MacKay DS, et al. Progress and perspectives in plant sterol and plant stanol research. Nutr Rev. 2018;76:725–46. This review is the most comprehensive and up-to-date review on plant sterol research.
Denke MA. Lack of efficacy of low-dose sitostanol therapy as an adjunct to a cholesterol-lowering diet in men with moderate hypercholesterolemia. Am J Clin Nutr. 1995;61:392–6.
Weingärtner O, Bogeski I, Kummerow C, et al. Plant sterol ester diet supplementation increases serum plant sterols and markers of cholesterol synthesis, but has no effect on total cholesterol levels. J Steroid Biochem Mol Biol. 2017;169:219–25.
Rajaratnam RA, Gylling H, Miettinen TA. Independent association of serum squalene and noncholesterol sterols with coronary artery disease in postmenopausal women. J Am Coll Cardiol. 2000;35:1185–91.
Assmann G, Cullen P, Erbey J, Ramey DR, Kannenberg F, Schulte H. Plasma sitosterol elevations are associated with an increased incidence of coronary events in men: results of a nested case-control analysis of the Prospective Cardiovascular Münster (PROCAM) study. Nutr Metab Cardiovasc Dis. 2006;16:13–21.
Weingärtner O, Weingärtner N, Scheller B, Lütjohann D, Gräber S, Schäfers H-J, et al. Alterations in cholesterol homeostasis are associated with coronary heart disease in patients with aortic stenosis. Coron Artery Dis. 2009;20:376–82.
Weingärtner O, Lütjohann D, Vanmierlo T, Müller S, Günther L, Herrmann W, et al. Markers of enhanced cholesterol absorption are a strong predictor for cardiovascular diseases in patients without diabetes mellitus. Chem Phys Lipids. 2011;164:451–6.
Matthan NR, Pencina M, LaRocque JM, Jacques PF, D’Agostino RB, Schaefer EJ, et al. Alterations in cholesterol absorption/synthesis markers characterize Framingham Offspring Study participants with CHD. J Lipid Res. 2009;50:1927–35.
Glueck CJ, Speirs J, Tracy T, Streicher P, Illig E, Vandegrift J. Relationships of serum plant sterols (phytosterols) and cholesterol in 595 hypercholesterolemic subjects, and familial aggregation of phytosterols, cholesterol, and premature coronary heart disease in hyperphytosterolemic probands and their first-degree relatives. Metabolism. 1991;40:842–8.
Sudhop T, Gottwald BM, von Bergmann K. Serum plant sterols as a potential risk factor for coronary heart disease. Metabolism. 2002;51:1519–21.
Pinedo S, Vissers MN, von Bergmann K, Elharchaoui K, Lütjohann D, Luben R, et al. Plasma levels of plant sterols and the risk of coronary artery disease: the prospective EPIC-Norfolk population study. J Lipid Res. 2007;48:139–44.
Windler E, Zyriax B-C, Kuipers F, Linseisen J, Boeing H. Association of plasma phytosterol concentrations with incident coronary heart disease. Atherosclerosis. 2009;203:284–90.
Silbernagel G, Fauler G, Hoffmann MM, Lütjohann D, Winkelmann BR, Boehm BO, et al. The associations of cholesterol metabolism and plasma plant sterols with all-cause and cardiovascular mortality. J Lipid Res. 2010;51:2384–93.
Thiery J, Ceglarek U, Fiedler GM, Leichtle A, Baumann S, Teupser D, et al. Abstract 4099: elevated campesterol serum levels—a significant predictor of incident myocardial infarction: results of the population-based MONICA/KORA follow-up study 1994 to 2005. Circulation. 2006;114:II_884.
Strandberg TE, Tilvis RS, Pitkala KH, Miettinen TA. Cholesterol and glucose metabolism and recurrent cardiovascular events among the elderly: a prospective study. J Am Coll Cardiol. 2006;48:708–14.
Fuhrmann A, Weingärtner O, Meyer S, et al. Plasma levels of the oxyphytosterol 7α-hydroxycampesterol are associated with cardiovascular events. Atherosclerosis. 2018;279:17–22. This original publication provides evidence that oxysterols are associated with cardiovascular events.
Genser B, Silbernagel G, De Backer G, et al. Plant sterols and cardiovascular disease: a systematic review and meta-analysis. Eur Heart J. 2012;33:444–51.
Altmann SW. Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption. Science. 2004;303:1201–4.
Teupser D, Baber R, Ceglarek U, et al. Genetic regulation of serum phytosterol levels and risk of coronary artery disease. Circ Cardiovasc Genet. 2010;3:331–9.
The Myocardial Infarction Genetics Consortium Investigators. Inactivating mutations in NPC1L1 and protection from coronary heart disease. N Engl J Med. 2014;371:2072–82.
Helgadottir A, Thorleifsson G, Alexandersson KF, et al. Genetic variability in the absorption of dietary sterols affects the risk of coronary artery disease. European Heart Journal. 2020;41:2618–28. This original publication provides genetic evidence that plant sterols “per se” are atherogenic.
Ratnayake WMN, L’Abbé MR, Mueller R, Hayward S, Plouffe L, Hollywood R, et al. Vegetable oils high in phytosterols make erythrocytes less deformable and shorten the life span of stroke-prone spontaneously hypertensive rats. J Nutr. 2000;130:1166–78.
Weingärtner O, Böhm M, Laufs U. Controversial role of plant sterol esters in the management of hypercholesterolaemia. Eur Heart J. 2009;30:404–9.
Malini T, Vanithakumari G. Antifertility effects of β-sitosterol in male albino rats. J Ethnopharmacol. 1991;35:149–53.
Solca C, Tint GS, Patel SB. Dietary xenosterols lead to infertility and loss of abdominal adipose tissue in sterolin-deficient mice. J Lipid Res. 2013;54:397–409.
Gilman CI, Leusch FDL, Carl Breckenridge W, MacLatchy DL. Effects of a phytosterol mixture on male fish plasma lipoprotein fractions and testis P450scc activity. Gen Comp Endocrinol. 2003;130:172–84.
Hendriks H, Weststrate J, van Vliet T, Meijer G. Spreads enriched with three different levels of vegetable oil sterols and the degree of cholesterol lowering in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr. 1999;53:319–27.
Gylling H, Puska P, Vartiainen E, Miettinen TA. Retinol, vitamin D, carotenes and α-tocopherol in serum of a moderately hypercholesterolemic population consuming sitostanol ester margarine. Atherosclerosis. 1999;145:279–85.
General view of the Scientific Committee on Food on the long-term effects of the intake of elevated levels of phytosterols from multiple dietary sources, with particular attention to the effects on β-carotene. European Comission. 2002. https://ec.europa.eu/food/system/files/2020-12/sci-com_scf_out143_en.pdf.